The Market for Biologic Drugs

Are biosimilars priced similarly to generics? According to Ana Nicholls, healthcare analyst at The Economist Intelligence Unit, the answer is no:

“Given the lower levels of competition in the biosimilars market, the copies tend to be priced at just 20-30% below the original drugs, compared with around 90% below for traditional generics.” (Jason Shafrin)

Comments (16)

Trackback URL | Comments RSS Feed

  1. Ewing says:

    So people are more likely to choose biosimilars?

  2. Lucas says:

    It appears that there are those willing to buy biosimilar drugs, but the costs need to go down in order to create a larger demand

  3. Trent says:

    I will probably just stick to generics

  4. Wally says:

    There’s a group wanting it, but more producers have to enter the market before they become a legit competitor with generics

  5. Jordan says:

    I feel as if reconstituted DNA in pill form is not the safest way to administer medicine

  6. Lisa Basset says:

    Thanks for sharing this awesome market biologic drugs information.

    http://www.vtightgel.us